 |
|
|
|
|
|
|
|
|
|
| |
 |
Upcoming Meetings
|
|
|
| |
|
Safety and Scientific Symposia |
|
|
| |
 |
Scientific Symposium - December 9-10, 2010
NIH RAC and CliniGene Scientific Symposium on "Retroviral and Lentiviral Vectors for Long-Term Gene Correction: Clinical Challenges in Vector and Trial Design"
|
|
|
| |
|
Safety Symposium - June 15, 2010
Gene-Modified T Cells: Challenges in Clinical Trial Design
|
|
|
| |
|
Safety Symposium on a Serious Adverse Event on OBA Protocol 705
|
|
|
| |
|
Safety Symposium - March 15, 2005
Current Perspectives on Gene Transfer for X-SCID
|
|
|
| |
|
Safety Symposium - September 21-22, 2004
Safety Considerations in Recombinant DNA Research with Pathogenic Viruses
|
|
|
| |
|
Safety Symposium - March 7, 2001
Safety Considerations in the Use of AAV Vectors in Gene Transfer Clinical Trials
|
|
|
| |
|
Safety Symposium - December 14, 2000
Safety Considerations in Cardiovascular Gene Transfer Clinical Research
|
|
|
| |
|
Safety Symposium - March 8, 2000
Internally Deleted, Helper-Dependent Adenoviral Vectors
|
|
|
| |
|
Biosafety Considerations for Research with Lentiviral Vectors |
|
|
| |
|
Policy Conferences |
|
|
| |
|
RNA Oligonucleotides: Emerging Clinical Applications (December 15-16,2011)
|
|
|
| |
|
Sham Neurological Procedures in Clinical Trials for Neurodegenerative Diseases: Scientific and Ethical Considerations (June 30, 2010 - July 1, 2010) |
|
|
| |
|
NIH Public Consultation on Proposed Changes to the NIH Guidelines for Synthetic Nucleic Acids (June 23, 2009) |
|
|
| |
|
Summaries and Reports of the Gene Therapy Policy Conferences (1998-Present)
|
|
|
| |
|
IBCs in a Changing Research Landscape: A Policy Conference
|
|
|
| |
|
Past Professional Development Conferences, Workshops, and Training Sessions |
|
|
| |
|
Institutional Biosafety Committees: Promoting Optimal Practice Now and in the Future
|
|
|
| |
|
The NIH System of Oversight of Human Gene Transfer Research: Optimizing Science, Safety and Ethics
|
|
|
| |
|
IBC Basics: An Introduction to the NIH Guidelines and the Oversight of Recombinant DNA Research
|
|
|
| |
|
The Future Face of IBCs: Evolving Roles and Responsibilities, Upcoming Challenges and Opportunities
|
|
| |
|
|
|
|
Upcoming Meetings |
|
|
|
|
|
Policy Conference - December 15-16, 2011: |
|
|
| |
RNA Oligonucleotides: Emerging Clinical Applications |
|
|
| |
|
Agenda |
|
|
| |
|
Webcast- December 15, 2011 - Day 1  |
|
|
| |
|
Webcast- December 16, 2011 - Day 2 |
|
Top of Page |
|
|
|
|
Scientific Symposium - December 9-10, 2010: |
|
|
| |
NIH RAC and CliniGene Scientific Symposium on "Retroviral and Lentiviral Vectors for Long-Term Gene Correction: Clinical Challenges in Vector and Trial Design"
|
|
|
| |
|
Agenda (with links to briefings) |
|
|
| |
|
Webcast- December 9, 2010 - Day 1 |
|
|
| |
|
Webcast- December 10, 2010 - Day 2 |
|
Top of Page |
|
|
|
|
Safety Symposium - June 15, 2010: |
|
|
| |
Gene-Modified T Cells: Challenges in Clinical Trial Design
|
|
|
| |
|
Agenda |
|
|
| |
|
Participant List |
|
|
| |
|
Webcast |
|
|
| |
|
RAC Points to Consider |
|
|
| |
|
Meeting Publication: Cancer Research |
|
|
| |
|
Reference Materials |
|
Top of Page |
|
|
|
|
Safety Symposium |
|
|
| |
Safety Symposium on a Serious Adverse Event on OBA Protocol 705:
|
|
|
| |
A Phase I/II Study of Repeat Intra-Articular Administration of tgAAC94, a Recombinant Adeno-Associated Vector Containing the TNFR:FC Fusion Gene in Inflammatory Arthritis with and without Concurrent TNF-a Antagonist
|
|
|
| |
|
Safety Symposium on a Serious Adverse Event on OBA Protocol 705 |
|
Top of Page |
|
|
|
|
Safety Symposium - March 15, 2005: |
|
|
| |
Current Perspectives on Gene Transfer for X-SCID
|
|
|
| |
|
Webcast - Morning session before break |
|
|
| |
|
Webcast - Morning session after break |
|
|
| |
|
Webcast - Afternoon session before break |
|
|
| |
|
Webcast - Afternoon session after break |
|
|
| |
|
Current Perspectives on Gene Transfer for X-linked Severe Combined Immunodeficiency Disease (X-SCID) |
|
Top of Page |
|
|
|
|
Safety Symposium - September 21-22, 2004: |
|
|
| |
Safety Considerations in Recombinant DNA Research with Pathogenic Viruses
|
|
|
| |
On September 21-22, 2004, NIH OBA held a safety symposium in conjunction with the meeting of the Recombinant DNA Advisory Committee (RAC). The symposium addressed safety considerations for recombinant DNA research with pathogenic viruses, focusing on containment issues for research with such viruses as 1918 influenza virus, highly pathogenic avian influenza viruses, and SARS Co-V. A major goal of the symposium was to develop a Points to Consider document and other resources to assist IBCs in conducting risk assessments and determining appropriate containment.
|
|
|
| |
|
Agenda and Participant List |
|
|
| |
|
Webcast - Day one - Morning session before break |
|
|
| |
|
Webcast - Day one - Morning session after break |
|
|
| |
|
Webcast - Day one - Afternoon session before break |
|
|
| |
|
Webcast - Day one - Afternoon session after break |
|
|
| |
|
Reference Information |
|
|
| |
|
Frequently Asked Questions - Risk Assessment and Determining Containment |
|
Top of Page |
|
|
|
|
Safety Symposium - March 7, 2001: |
|
|
| |
Safety Considerations in the Use of AAV Vectors in Gene Transfer Clinical Trials
|
|
|
| |
|
Transcript |
|
Top of Page |
|
|
|
|
Safety Symposium - December 14, 2000: |
|
|
| |
Safety Considerations in Cardiovascular Gene Transfer Clinical Research
|
|
|
| |
|
Transcript |
|
Top of Page |
|
|
|
|
Safety Symposium - March 8, 2000: |
|
|
| |
Internally Deleted, Helper-Dependent Adenoviral Vectors
|
|
|
| |
|
Transcript |
|
|
| |
|
Summary |
|
Top of Page |
|
|
|
|
Summaries and Reports of the Gene Therapy Policy Conferences (1998-Present) |
|
|
| |
Prenatal Gene Therapy: Scientific, Medical, & Ethical Issues - January 7-8, 1999 |
|
|
| |
|
Full Report |
|
|
| |
|
Summary |
|
|
| |
|
RAC Statement Regarding In Utero Gene Transfer Research |
|
|
| |
Lentiviral Vectors for Gene Delivery - March 9, 1998 |
|
|
| |
|
Summary |
|
|
| |
|
Preclinical Safety Evaluation of Lentivirus Vectors: FDA Regulatory Expectations - Anne M. Pilaro, Ph.D. |
|
Top of Page |
|
|
|
|
"IBCs in a Changing Research Landscape: A Policy Conference" |
|
|
| |
Bethesda, Marriott, December 7-8, 2001 |
|
|
| |
|
Conference Summary |
|
|
| |
|
Webcasts Day 1 |
|
|
| |
|
Welcome |
|
|
| |
|
Session 1 |
|
|
| |
|
Session 2 |
|
|
| |
|
Session 3 |
|
|
| |
|
Session 4 |
|
|
| |
|
Webcasts Day 2 |
|
|
| |
|
Morning Session |
|
|
| |
|
Afternoon Session |
|
